| Author | Title | Source | Year |
| Chao-Ming Hung , Kuo-Chuan Hung, Jaw-Town Lin, Kun-Ming Rau , Hui-Ming Lee, Chong-Chi Chiu. | Comment on: Histopathological assessment of the gallbladder after routine cholecystectomy is essential for high-quality healthcare. | Br J Surg. 2022 Sep 2:znac312. doi: 10.1093/bjs/znac312. Epub ahead of print. | 2022 |
| Meng-Che Hsieh, Kun-Ming Rau, Shung-Eing Lin, Kuang-Wen Liu, Chong-Chi Chiu, Chih-I Chen, Ling-Chiao Song, Hsin-Pao Chen. | An Observational Study of Trifluridine/Tipiracil-Containing Regimen Versus Regorafenib-Containing Regimen in Patients With Metastatic Colorectal Cancer. | Front Oncol. 2022 May 19;12:867546. doi: 10.3389/fonc.2022.867546. | 2022 |
| Chao-Ming Hung, Po-Huang Lee, Chao-Sung Chang, Kun-Ming Rau, Jung-Fa Tsai, Chong-Chi Chiu. | Comment on: Antibiotics as first-line alternative to appendicectomy in adult appendicitis: 90-day follow-up from a prospective, multicentre cohort study. | Br J Surg. 2022 Apr 19;109(5):e76. doi: 10.1093/bjs/znac036. | 2022 |
| Ryoo BY, Cheng AL, Ren Z, Kim TY, Pan H, Rau KM, Choi HJ, Park JW, Kim JH, Yen CJ, Lim HY, Zhou D, Straub J, Scheele J, Berghoff K, Qin S. | Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression. | Br J Cancer. 2021 Jul;125(2):200-208. doi: 10.1038/s41416-021-01380-3. | 2021 |
| Kudo M, Finn RS, Morimoto M, Rau KM, Ikeda M, Yen CJ, Galle PR, Llovet JM, Daniele B, Lim HY, McIlwain DW, Yoshikawa R, Nakamura K, Liang K, Wang C, Abada P, Widau RC, Zhu AX. | Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2). | Liver Cancer. 2021 Jul 12;10(5):451-460. doi: 10.1159/000516605. | 2021 |
| Ming Shen Dai, Yin Hsun Feng, Shang Wen Chen, et al. | Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two … | Breast Cancer Res Treat. 2021 Oct;189(3):665-676. doi: 10.1007/s10549-021-06313-5. | 2021 |
| Chien-Ting Liu, Meng-Che Hsieh, Yu-Li Su, Chaio-Ming Hung, Sung-Nan Pei, Chun-Kai Liao, Yu-Fen Tsai, Hsiu-Yun Liao, Wei-Ching Liu, Chong-Chi Chiu, Shih-Chung Wu, Shih-Ho Wang, Ching-Ting Wei, Kun-Ming Rau. | Metronomic vinorelbine is an excellent and safe treatment for advanced breast cancer: a retrospective, observational study. | J Cancer. 2021 Jul 3;12(17):5355-5364. doi: 10.7150/jca.60682. | 2021 |
| Sung-Nan Pei, Chun-Kai Liao, Yaw-Sen Chen, Cheng-Hao Tseng, Chao-Ming Hung, Chong-Chi Chiu6, Meng-Che Hsieh, Yu-Fen Tsai, Hsiu-Yun Liao, Wei-Ching Liu, Kun-Ming Rau. | A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study. | Cancers (Basel). 2021 Jul 29;13(15):3831. | 2021 |
| Chong-Chi Chiu, Po-Huang Lee, Chao-Sung Chang, Kun-Ming Rau, Chao-Ming Hung. | Correspondence to 'Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results'. | Br J Surg. 2021 Mar 12;108(2):e93. doi: 10.1093/bjs/znaa126. | 2021 |
| Kun-Ming Rau, Chao-Sung Chang, Sung-Nan Pei, Meng-Che Hsieh, Yu-Fen Tsai, Chong-Chi Chiu. | Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis. | Br J Surg. 2021 May 27;108(5):e211. doi: 10.1093/bjs/znab055. | 2021 |
| Hui-Ju Tsai, Ju-Chien Cheng, Man-Leng Kao, Hung-Pin Chiu, Yi-Hsuan Chiang, Ding-Ping Chen, Kun-Ming Rau, Hsiang-Ruei Liao, Ching-Ping Tseng. | Integrin αIIbβ3 outside-in signaling activates human platelets through serine 24 phosphorylation of Disabled-2. | Cell Biosci. 2021 Feb 8;11(1):32. doi: 10.1186/s13578-021-00532-5. | 2021 |
| Meng-Che Hsieh, Shih-Ho Wang, Ching-Ting Wei, Chung-Yen Chen, Yen-Yang Chen, Sung-Nan Pei, Yu-Fen Tsai, Kun-Ming Rau. | S1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection-A Propensity Score Matching Analysis. | Cancers (Basel). 2020 Aug 23;12(9):E2384. doi: 10.3390/cancers12092384. PMID: 32842507. | 2020 |